These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27364506)

  • 21. Women's preferences for contralateral prophylactic mastectomy: An investigation using protection motivation theory.
    Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Musiello T; Marven M; Butow P
    Patient Educ Couns; 2016 May; 99(5):814-22. PubMed ID: 27529090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.
    Elsayegh N; Webster RD; Gutierrez Barrera AM; Lin H; Kuerer HM; Litton JK; Bedrosian I; Arun BK
    Cancer Med; 2018 Jun; 7(6):2718-2726. PubMed ID: 29733510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Cost of Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer.
    Billig JI; Duncan A; Zhong L; Aliu O; Sears ED; Chung KC; Momoh AO
    Plast Reconstr Surg; 2018 May; 141(5):1094-1102. PubMed ID: 29659447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study.
    Jakub JW; Peled AW; Gray RJ; Greenup RA; Kiluk JV; Sacchini V; McLaughlin SA; Tchou JC; Vierkant RA; Degnim AC; Willey S
    JAMA Surg; 2018 Feb; 153(2):123-129. PubMed ID: 28903167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast reconstruction in patients with personal and family history of breast cancer undergoing contralateral prophylactic mastectomy, a 10-year experience.
    Unukovych D; Sandelin K; Wickman M; Arver B; Johansson H; Brandberg Y; Liljegren A
    Acta Oncol; 2012 Sep; 51(7):934-41. PubMed ID: 22409595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations.
    Howard-McNatt M; Schroll RW; Hurt GJ; Levine EA
    Am J Surg; 2011 Sep; 202(3):298-302. PubMed ID: 21871984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors.
    Graves KD; Peshkin BN; Halbert CH; DeMarco TA; Isaacs C; Schwartz MD
    Breast Cancer Res Treat; 2007 Sep; 104(3):321-9. PubMed ID: 17066320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
    Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
    Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative Genetic Testing Does Not Deter Contralateral Prophylactic Mastectomy in Younger Patients with Greater Family Histories of Breast Cancer.
    Wang F; Amara D; Peled AW; Sbitany H; Foster RD; Ewing CA; Alvarado M; Esserman LJ
    Ann Surg Oncol; 2015 Oct; 22(10):3338-45. PubMed ID: 26215194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contralateral Prophylactic Mastectomy: Factors Predictive of Occult Malignancy or High-Risk Lesion and the Impact of MRI and Genetic Testing.
    Erdahl LM; Boughey JC; Hoskin TL; Degnim AC; Hieken TJ
    Ann Surg Oncol; 2016 Jan; 23(1):72-7. PubMed ID: 26065870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contralateral prophylactic mastectomy (CPM): A systematic review of patient reported factors and psychological predictors influencing choice and satisfaction.
    Ager B; Butow P; Jansen J; Phillips KA; Porter D;
    Breast; 2016 Aug; 28():107-20. PubMed ID: 27290619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The financial impact and drivers of hospital charges in contralateral prophylactic mastectomy and reconstruction: a Nationwide Inpatient Sample hospital analysis.
    Bucknor A; Chattha A; Ultee K; Wu W; Kamali P; Bletsis P; Chen A; Lee BT; Cronin C; Lin SJ
    Breast Cancer Res Treat; 2017 Sep; 165(2):301-310. PubMed ID: 28634720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Issues of regret in women with contralateral prophylactic mastectomies.
    Montgomery LL; Tran KN; Heelan MC; Van Zee KJ; Massie MJ; Payne DK; Borgen PI
    Ann Surg Oncol; 1999 Sep; 6(6):546-52. PubMed ID: 10493622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution.
    Jones NB; Wilson J; Kotur L; Stephens J; Farrar WB; Agnese DM
    Ann Surg Oncol; 2009 Oct; 16(10):2691-6. PubMed ID: 19506956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.
    Yi M; Hunt KK; Arun BK; Bedrosian I; Barrera AG; Do KA; Kuerer HM; Babiera GV; Mittendorf EA; Ready K; Litton J; Meric-Bernstam F
    Cancer Prev Res (Phila); 2010 Aug; 3(8):1026-34. PubMed ID: 20647335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy.
    Schmidt MK; Kelly JE; Brédart A; Cameron DA; de Boniface J; Easton DF; Offersen BV; Poulakaki F; Rubio IT; Sardanelli F; Schmutzler R; Spanic T; Weigelt B; Rutgers EJT
    Eur J Cancer; 2023 Mar; 181():79-91. PubMed ID: 36641897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contralateral breast cancer and tumor recurrence in BRCA1/2 carriers and non-carriers at a high risk of hereditary breast cancer after bilateral mastectomy.
    Allué Cabañuz M; Domingo Bretón M; Chóliz Ezquerro J; Arribas Del Amo MD; Güemes Sánchez AT
    Cir Esp (Engl Ed); 2020 Dec; 98(10):612-617. PubMed ID: 32505558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
    J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancer: A large population-based study in the Surveillance, Epidemiology, and End Results database 18.
    Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
    Breast; 2017 Oct; 35():48-54. PubMed ID: 28649032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer.
    Terkelsen T; Rønning H; Skytte AB
    Acta Oncol; 2020 Jan; 59(1):60-65. PubMed ID: 31379231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.